Standout Papers

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibit... 2012 2026 2016 2021 480
  1. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma (2012)
    Loredana Santo, Teru Hideshima et al. Blood

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

Recent Advances in 3D Printing of Smart Scaffolds for Bone Tissue Engineering and Regeneration
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
2 intermediate papers

Works of Homare Eda being referenced

Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
2016

Author Peers

Author Last Decade Papers Cites
Homare Eda 360 803 475 29 1.0k
Jan Sterz 389 651 407 23 931
Babita Saigal 168 713 456 26 1.2k
Shengyan Xiang 134 751 268 24 898
J. Nathan Davis 372 970 370 26 1.4k
Isere Kuiatse 213 677 266 36 930
Derek Mendy 754 1098 511 21 1.3k
Matthew A. Lawlor 146 1003 265 20 1.1k
Mohamed Békradda 366 880 432 29 1.3k
Vernon T. Phan 202 579 252 16 869
Sara Volorio 315 893 267 26 1.1k

All Works

Loading papers...

Rankless by CCL
2026